Active ingredientCarbamazepineCat. No. P-C033-001CAS 298-46-4Family · Pharmaceutical analytical standards
Carbamazepine
An antiepileptic discovered in 1953 in Basel by chemist Walter Schindler and marketed in Switzerland from 1963: it is used for epilepsy and nerve pain, and is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?In the United States it is the only medicine approved by the FDA for trigeminal neuralgia, a sudden, intense pain that affects the face.
Go to the active ingredient →Active ingredientCarbamazepineCat. No. P-C033-001CAS 298-46-4
Impurity10-Methoxy CarbamazepineCat. No. P-C033-002CAS 28721-09-7
Pharmacopoeial impurityCarbamazepine EP Impurity ACat. No. P-C033-003CAS 3564-73-6
Pharmacopoeial impurityCarbamazepine EP Impurity BCat. No. P-C033-004CAS 611-64-3
Pharmacopoeial impurityCarbamazepine EP Impurity CCat. No. P-C033-005CAS 1219170-51-0
Pharmacopoeial impurityCarbamazepine EP Impurity DCat. No. P-C033-006CAS 256-96-2
Pharmacopoeial impurityCarbamazepine EP Impurity ECat. No. P-C033-007CAS 494-19-9
Pharmacopoeial impurityCarbamazepine EP Impurity FCat. No. P-C033-008CAS 33948-22-0
Pharmacopoeial impurityCarbamazepine EP Impurity GCat. No. P-C033-009CAS 59690-97-0
MetaboliteCarbamazepine N-GlucuronideCat. No. P-C033-010CAS 60342-79-2
Isotopically labelledCarbamazepine Impurity 5 (Mixture of Diastereomers)-d4Cat. No. P-C033-012
Isotopically labelledCarbamazepine 10,11-Epoxide-d10Cat. No. P-C033-013CAS 1219804-16-6
Isotopically labelledCarbamazepine-d10Cat. No. P-C033-015CAS 132183-78-9
Isotopically labelledCarbamazepine-d4Cat. No. P-C033-016
NitrosamineN-Nitroso Carbamazepine EP Impurity ECat. No. P-C033-017CAS 7458-08-4
Impurity(R)-LicarbazepineCat. No. P-C033-018CAS 104746-03-4
Impurity(R)-Licarbazepine AcetateCat. No. P-C033-019CAS 186694-45-1
Impurity(S)-LicarbazepineCat. No. P-C033-020CAS 104746-04-5
ImpurityCarbamazepine Impurity 1Cat. No. P-C033-021CAS 13080-75-6
ImpurityCarbamazepine Impurity 2Cat. No. P-C033-022CAS 132648-81-8
ImpurityCarbamazepine Impurity 3 BromideCat. No. P-C033-023CAS 866873-98-5
ImpurityCarbamazepine Impurity 4Cat. No. P-C033-024CAS 40421-03-2
ImpurityDihydroxycarbazepineCat. No. P-C033-026CAS 35079-97-1
ImpurityCarbamazepine Impurity 6Cat. No. P-C033-027CAS 78880-65-6
ImpurityCarbamazepine Impurity 7Cat. No. P-C033-028CAS 33948-19-5
Impurity10-Bromo-5-bromocarbonyliminostilbeneCat. No. P-C033-029CAS 53003-61-5
ImpurityCarbamazepine Impurity 8Cat. No. P-C033-030CAS 143667-53-2![10-Bromo-5H-dibenzo[b,f]azepine](https://img.vitasanlabs.com/vsl-struct/P-C033-031.svg?v=41e934f030)
Impurity10-Bromo-5H-dibenzo[b,f]azepineCat. No. P-C033-031CAS 75272-34-3
Impurity10-Hydroxy-10,11-dihydrocarbamazepineCat. No. P-C033-032CAS 29331-92-8
Impurity10-HydroxyiminodibenzylCat. No. P-C033-033CAS 4014-77-1
Impurity2,2'-DinitrobibenzylCat. No. P-C033-034CAS 16968-19-7
Impurity2,2'-EthylenedianilineCat. No. P-C033-035CAS 34124-14-6
Impurity2-Methyl-5H-dibenz(b,f)azepineCat. No. P-C033-036CAS 70401-31-9
ImpurityCarbamazepine Impurity 9Cat. No. P-C033-037CAS 70401-32-0
ImpurityCarbamazepine Impurity 10Cat. No. P-C033-038CAS 13080-74-5
Impurity3-Hydroxy CarbamazepineCat. No. P-C033-039CAS 68011-67-6
ImpurityCarbamazepine Impurity 11Cat. No. P-C033-040CAS 25961-11-9
ImpurityCarbamazepine 10,11-EpoxideCat. No. P-C033-041CAS 36507-30-9
ImpurityMethyl CarbamateCat. No. P-C033-042CAS 598-55-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceCarbamazepine CRSEDQM code C0450000Family CarbamazepineImpurityCarbamazepine impurity A CRSEDQM code Y0000033Family CarbamazepineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.